219677-82-4
Lisinopril Impurity D
C21H29N3O4
MW = 387.47
(2S)-2-[(3S,8aR)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4- phenylbutanoic Acid (R,S,S-Diketopiperazine)
Technical Data
| C21H29N3O4 | |
|---|---|
| MW = 387.47 | |
| Optical rotation = [α]D20 65.40° | |
| White to off-white solid |
Storage Shipping
| H303 - May be harmful if swallowed | |
|---|---|
| H313 - May be harmful in contact with skin | |
| P280 - Wear protective gloves/protective clothing/eye protection/face protection. | |
| Store at 2-8°C, ship at ambient temperature |
Description
Lisinopril EP Impurity D; (2S)-2-[(3S,8aR)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4- phenylbutanoic Acid (R,S,S-Diketopiperazine); CAS 219677-82-4 is the R,S,S-Diketopiperazine impurity of Lisinopril, an angiotensin-converting enzyme inhibitor class drug used to treat high blood pressure, heart failure, and after heart attacks.
